Public Company News & Press Release Distribution

Canadian Solar Becomes the Largest Solar Developer in Italy After Signing 84 MWp PPA with Axpo Italia

GUELPH, ON, March 8, 2022 /PRNewswire/ -- Canadian Solar Inc. ("Canadian Solar" or the "Company") (NASDAQ: CSIQ) today announced it has signed two 10-year power purchase agreements (PPA) with AxpoItalia for the purchase of 70% of energy produced by two solar power...

2022-03-08 20:00 2920

Jinko Power Announces PPA Signing for Saad 300 MW solar PV near Riyadh in the Kingdom of Saudi Arabia

SHANGHAI, March 8, 2022 /PRNewswire/ -- Jinko Power Technology Co., Ltd, (the "Company" or "JinkoPower" (601778.SH) announced today that it was awarded the Saad 300MWp Solar PV Project in the recent public auction for Round 3 Category "B" solar PV projects bySaudi Arabia's Ministry of Energy. Th...

2022-03-08 17:38 3827

Green Era Launches Renewables Portfolio through the Acquisition of a 33.33% Stake in Star Energy for USD 440 million

* Inaugural acquisition by Green Era Pte Ltd (Green Era), a Pangestu Family Office special purpose vehicle based inSingapore, to launch its Southeast Asian renewables asset portfolio * Star Energy Group Holdings Pte. Ltd. (Star Energy) is a holding company with subsidiaries that hold worldlea...

2022-03-08 17:11 11561

Green Era Launches Renewables Portfolio through the Acquisition of a 33.33% Stake in Star Energy for USD 440 million

Acer Reports February Consolidated Revenues of NT$22.91 Billion, the Highest in Eight Years

TAIPEI, March 8, 2022 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced today its consolidated revenues forFebruary 2022 at NT$22.91 billion, the highest in eight years for the same period. The February revenues grew by 12.7% year-on-year (YoY), and year-to-February revenues ofNT$48.06 billion gre...

2022-03-08 17:07 2362

Hyundai IONIQ 5 Named UK Car of the Year 2022

* Ground-breaking Hyundai IONIQ 5 takes top honor at the UK Car of the Year Awards * 298-mile range EV also crowned Best Family Car * Hailed by judges as "the future of motoring, but here today" * Follows a string of prestigious awards throughout 2021 and early 2022 * Hyundai i20N also re...

2022-03-08 17:00 2812

Hyundai IONIQ 5 Named UK Car of the Year 2022

Yum China Ranked Among the Top 100 Companies Globally for Gender Equality by Equileap

SHANGHAI, March 8, 2022 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) today announced it has been ranked among the leading companies worldwide in the 2022 edition of Equileap's Top 100 Gender Equality Global Ranking.Yum China is the only compan...

2022-03-08 16:30 2647

NetDragon's Promethean ActivPanel Remains Global Market Leader for Interactive Displays

HONG KONG, March 8, 2022 /PRNewswire/ -- NetDragon Websoft Holdings Limited ("NetDragon" or "the Company", Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce that its subsidiary Promethean, continues to be a global leader for Interactive Flat Pane...

2022-03-08 15:18 4941

Newborn Town (9911.HK) Announced Profit Alert: Revenue and Adjusted Net Income Doubled in 2021

HONG KONG, March 8, 2022 /PRNewswire/ -- Newborn Town (9911.HK), the largest Chinese social networking enterprise going global, released a profit alert on March 8th. The Company expected its revenue and adjusted net profit doubled, while adjusted EBITDA expected to increase significantly. I. Reve...

2022-03-08 14:05 4014

Gaotu Techedu Announces Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results

BEIJING, March 8, 2022 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a technology-driven education company and online large-class tutoring service provider inChina, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 3...

2022-03-08 13:02 5288

Gaotu Techedu Announces Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results

BEIJING, March 8, 2022 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a technology-driven education company and online large-class tutoring service provider inChina, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 3...

2022-03-08 13:00 3246

Akeso Announces IND Approval from China NMPA for Phase II Clinical Trial of Cadonilimab in Combination with Docetaxel to Treat NSCLC

HONG KONG, March 7, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso"), a biopharmaceutical company dedicated to the development of innovative antibody drugs, today announced that the Center for Drug Evaluation (CDE) ofChina's National Medical Products Administration (NMPA) has approved the IND...

2022-03-08 11:49 2516

Creating a Sustainable Workplace, Hisense Encourages Females to Achieve Better-self in Every Aspects

QINGDAO, China, March 8, 2022 /PRNewswire/ -- As the World Economic Forum's Global Gender Gap Report 2021 finds that gender equality is over 135.6 years away, meaning the world needs to pay more attention to achieving gender ...

2022-03-08 09:00 4819

Creating a Sustainable Workplace, Hisense Encourages Females to Achieve Better-self in Every Aspects

Damstra Technology Wins SNMPE 2021 Technology Innovation Award

MELBOURNE, Australia, March 8, 2022 /PRNewswire/ -- Damstra Technology , the Australian-based global leader in end-to-end contractor management software solutions, was recently selected as the winner of the "International Supplier of Excellence" category and receive...

2022-03-08 08:15 3361

Bridge Biotherapeutics Enters into an Option-to-License Agreement with CellionBioMed to Develop BBT-301 for the Treatment of Multiple Fibrotic Diseases

* The company reinforces its strategic focus on fibrotic diseases including idiopathic pulmonary fibrosis (IPF) * Through the option-to-license agreement, Bridge will develop a novel anti-fibrotic ion channel modulator, which is a preclinical candidate SEONGNAM, South Korea, March 7, 2022 /PR...

2022-03-08 08:00 2370

WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies

PHILADELPHIA, March 7, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA™). This technology is a state-of-the-art novel process for transfection-free, scalable manu...

2022-03-08 08:00 2341

BMO Proxy Circular and 2021 Sustainability Reporting Suite Now Available

TORONTO and CHICAGO, March 8, 2022 /PRNewswire/ -- BMO Financial Group (TSX: BMO) (NYSE: BMO) today announced that it has filed its 2022 Notice of Annual Meeting of Shareholders and Management Proxy Circular with applicable securities regulators. It further announced the release of its 2021 Sust...

2022-03-08 04:45 2135

AsiaInfo Announces 2021 Annual Results

HIGHLIGHTS: * Operating revenue amounted to approximately RMB 6,895 million, representing a year-on-year increase of 14.5%; * Revenue of Three New business1 amounted to approximately RMB 1,568 million, representing a year-on-year increase of 101.0%; * Gross profit amounted to approximately ...

2022-03-08 02:24 3808

TIAN RUIXIANG Holdings Ltd Reports Fiscal Year 2021 Financial Results

BEIJING, March 7, 2022 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX ) (the "Company"), a China-based insurance broker conducting business throu...

2022-03-07 22:00 3668

Origin Agritech Establishes New Subsidiary to Expand Its Nutrition Enhanced Corn Production

BEIJING, March 7, 2022 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that the company established a new subsidiary inHainan island to expand the capacity of nutrition enhanced corn production. The new wholly o...

2022-03-07 21:45 3691

Alterity Therapeutics to Present at the 34th Annual Roth Conference

MELBOURNE, Australia and SAN FRANCISCO, March 7, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced thatDavid Stamler, M.D.,...

2022-03-07 20:59 2798